The herein presented data reveal that measurement of L1CAM expression at the transcriptome levels in ovarian cancer tissue could potentially serve as a tool to predict the clinical outcome in ovarian cancer and underscores the importance of this adhesion molecule in the tumor biology of ovarian cancer. This evidence concerns the gene L1CAM and ovarian cancer.